BEIJING,Nov. 19,2024-- With the support of the RiDYMO® platform,we are able to comprehensively explore various potential targets in drug development,including protein-protein interactions,kinases,
The investment will initially focus on expediting development at existing sites inNavi Mumbai and Ambattur,Chennai,with an additional third site to be added in future.
XIAMEN,China,Nov. 19,2024-- In the fiscal year ended June 30,2024,POP CULTURE GROUP CO.,LTD. ("Pop Culture," or the "Company," Nasdaq: CPOP) continued to focus on its three busines
48-week end-of-treatment data from theongoing Phase 2 ENSURE study clearly demonstrated the added benefits of elebsiran towards achieving a higher functional cure rate in combination with PEG-IFNα
Database pioneer continues to scale at $2B+ valuation as GenAI accelerates demand
SAN MATEO,Calif.,Nov. 19,2024--Neo4j®,the world\'s leading graph database and analytics company,announced that it
NANTONG and SUZHOU,China,Nov. 19,2024-- Ractigen Therapeutics,a clinical-stage pharmaceutical company dedicated to developing innovative therapies,today announced that the U.S. Food and Drug Administr
GUANGZHOU,China,Nov. 19,2024-- On November 16th,the 2024 TCL CSOT Global Display Tech-ecosystem Conference (DTC2024) kicked off with great fanfare. The event brought together display industry experts,
LOS ANGELES,Nov. 19,2024-- Quinn Emanuel filed a lawsuit today in California against Anthony ("Tony") Buzbeefor extortion based on Buzbee\'s threats of publicizing false information for fin
